Skip to main content
Clinical Trials/NCT05972005
NCT05972005
Recruiting
N/A

Stronger At Home: Improve Functional Outcomes for Community-dwelling Older Adults After Hip Fracture

Dr. Mohammad Auais, PhD1 site in 1 country200 target enrollmentOctober 17, 2023
ConditionsHip Fractures

Overview

Phase
N/A
Intervention
Not specified
Conditions
Hip Fractures
Sponsor
Dr. Mohammad Auais, PhD
Enrollment
200
Locations
1
Primary Endpoint
The Lower Extremity Functional Scale (LEFS)
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

The goal of this clinical trial is to compare the effectiveness of a new 14-week individually-tailored home-based rehabilitation program called "Stronger at Home" with usual care in improving functional recovery in community-dwelling older adults after hip fractures.

The main question this trial aims to answer are:

• Is the Stronger at Home program more effective than usual care in improving functional recovery at the end of the 14-week intervention?

secondary questions include:

  • What is the cost-utility of the Stronger at Home program compared to usual care at 3.5 months, 6 months, and 12 months after discharge?
  • Does the program have a sustained impact on functional recovery at 6 months and 12 months post-discharge?

Participants in the trial will be asked to engage in the following tasks:

  • Participate in the Stronger at Home program, which includes using a self-directed toolkit consisting of educational resources and an illustrated exercise program.
  • Follow the guidelines provided in the toolkit for gradually increasing exercise intensity and incorporating different types of exercises into their daily life.

The effects of the Stronger at Home program will be compared to those of usual care.

Detailed Description

The primary research question of this project is whether the Stronger at Home program, a 14-week individually-tailored home-based rehabilitation program, is more effective than usual care in improving functional recovery in community-dwelling older adults after hip fractures. The evaluation of effectiveness will be conducted at the end of the intervention, which is the primary time point. In addition to the main research question, secondary aims of the project include evaluating the cost-utility of the Stronger at Home program compared to usual care at 3.5 months, 6 months, and 12 months after discharge. The program's impact on functional recovery will also be assessed at medium-term (6 months) and long-term (12 months) follow-ups after the participants are discharged from the hospital to their homes. The need for conducting this trial arises from a knowledge gap in effective rehabilitation programs for community-dwelling individuals with hip fractures. The Stronger at Home program was developed through a multistage study incorporating a self-directed toolkit and a new model of care. The development process involved critical analysis of previous programs, adherence to four principles of a successful program, and consultations with researchers, policymakers, older adults, and clinicians. The toolkit includes an educational component and an illustrated exercise program with progressively increasing intensity. The pilot study of the Stronger at Home program has shown feasibility, with positive feedback from healthcare providers and patients regarding its value.

Registry
clinicaltrials.gov
Start Date
October 17, 2023
End Date
July 29, 2028
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Dr. Mohammad Auais, PhD
Responsible Party
Sponsor Investigator
Principal Investigator

Dr. Mohammad Auais, PhD

Associate Professor, School Of Rehabilitation Therapy

Kingston Health Sciences Centre

Eligibility Criteria

Inclusion Criteria

  • Hip fracture patients who are 55 years or older,
  • Currently living in the community, and
  • Either being discharged to their home or a retirement home
  • Fall from a standing height or less
  • Live within 45km radius of recruitment site

Exclusion Criteria

  • Came from long term care or discharged to long term care
  • Not a hip fracture (e.g., pelvic fracture)
  • Unable to give consent and no proxy
  • Fracture due to pathological disease (e.g., cancer, Paget's disease).
  • Does not speak English and no translator
  • Fracture sustained at hospital
  • Terminal illness or exercise contraindications
  • Discharged with other services not eligible

Outcomes

Primary Outcomes

The Lower Extremity Functional Scale (LEFS)

Time Frame: 3.5 months (post intervention )

The primary outcome of the study (functional abilities) will be assessed using the Lower Extremity Functional Scale (LEFS), a patient-reported outcome measure consisting of 20 items. The LEFS has been validated for various populations, including patients recovering from hip surgeries, and has shown excellent reliability, validity, and responsiveness. It provides a score ranging from 0 to 80 based on the responses to each item's options. The LEFS was chosen based on its ability to evaluate important functional activities for patients, and its use as a primary outcome in the pilot study helped determine the sample size for this trial.

Secondary Outcomes

  • Clinical Frailty Scale(Baseline and 3.5 months, 6 months, 12 months after discharge)
  • Short Fear of Falling Scale(Baseline, and 3.5 months, 4.5 months, 6 months, 7.5 months, 9 months, 10.5 months, and 12 months after discharge.)
  • The Short Physical Performance Battery (SPPB)(Baseline, and at 3.5 months, 6 months, and 12 months after discharge.)
  • Modified Falls Efficacy Scale(Baseline, and 3.5 months, 4.5 months, 6 months, 7.5 months, 9 months, 10.5 months, and 12 months after discharge.)
  • Pain measured with Numerical Analogue Scale (NAS)(Baseline, and 3.5 months, 4.5 months, 6 months, 7.5 months, 9 months, 10.5 months, and 12 months after discharge.)
  • Tampa Scale of Kinesiophobia (TSK)(Baseline, and 3.5 months, 4.5 months, 6 months, 7.5 months, 9 months, 10.5 months, and 12 months after discharge.)
  • Short Depression Scale(Baseline, and 4.5 months, 7.5 months, 9 months, and 10.5 months after discharge)
  • 2-Minute Walk Test (2MWT)(Baseline, and at 3.5 months, 6 months, and 12 months after discharge.)

Study Sites (1)

Loading locations...

Similar Trials